Trial Site Detail

 

Drug:
Imatinib
Trial:
A Study of Intermittent Dosing Schedule of Imatinib in Patients With Tyrosine Kinase Inhibitor Refractory GISTs
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Unknown

 

Asan Medical center

     
Seoul , Songpa-gu 138-736
Republic of Korea

 

Principal Investigator:
 Min-Hee Ryu, MD, PhD
Contact:
 Min-Hee Ryu, MD, PhD 82-2-3010-5935 miniryu@amc.seoul.kr
Activation Status of this Site:
 Active
Notes about this Site:
Asan Medical center Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.